News - Page 6
NB win Phase II of CRACK IT Challenge 29: ImmuLiver
Newcells Biotech are excited to announce that they are Phase II contract winners of the NC3Rs-funded CRACK IT Challenge (named ImmuLiver). They have been awarded a further funding to…
Read update
NB hiPSC lung models; Valuable tools in understanding health impacts of air pollution
In 2014, the World Health Organisation (WHO) estimated that air pollution leads to 7 million deaths per year. This figure is more than the number of deaths from…
Read update
Newcells Biotech acquires IP for retinal organoids
Newcells Biotech is pleased to announce the acquisition of intellectual property pertaining to the methodology for the differentiation of three-dimensional retinal organoids from…
Read update
Vision for the future of childhood retinal dystrophies
The retina is the means through which most people primarily perceive the world and for children particularly, visual defects can affect educational, social and emotional development.1 The importance of retinal…
Read update
NB RPE model to improve drug retinal toxicity assessment
Retinal toxicity is an adverse side effect that can cause (usually irreversible) deterioration of a person’s vision, when taking certain medication. This has…
Read update
iPSC derived retinal organoids: A promising tool for modelling retinitis pigmentosa
Retinitis pigmentosa (RP) is a group of degenerative disorders of the retina, caused by mutations in one of more than 60 genes, including the genes for making rhodopsin
Read update
Newcells Biotech technology: the fight against antibacterial resistance
Antibacterial resistance is an ever-increasing concern for today’s society. As more bacterial strains become resistant to greater numbers of antibiotics, we could see modern-day healthcare rewind back to the…
Read updateNB win Phase I of CRACK IT Challenge 29: ImmuLiver – securing £99,711 funding
Newcells Biotech are one…
Read update
Looking forward: A year in review
2018 has been a significant year for Newcells Biotech. We have secured substantial investment, launched new, ground-breaking products, attended global events and expanded our every growing team. Here are some of…
Read update
Newcells head to Boston
International Trade Mission
Read update
ESTIV 2018 International Congress
Congress Round-Up The International Congress on In Vitro Toxicology (ESTIV2018) organised by the European Society of Toxicology was held in Berlin this October 2018. This year marks its 20th meeting, with the general theme of new…
Read update
iPSC-derived retinal organoids
The start of the field of stem cell biology dates back to 1938, when Hans Spemann suggested that a differentiated nucleus can express pluripotency. This was followed by decades…
Read update
